المؤلفون: D.S. Siegel, K. Weisel, A. Zahlten-Kumeli, R. Medhekar, S. Sapra, B. Ding, X. Leleu

المصدر: Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 260- (2020)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2531137920307227; https://doaj.org/toc/2531-1379

URL الوصول: https://doaj.org/article/6394fd0540d742f9832c0c81dbb8141c

المؤلفون: H. Quach, A. Nooka, O. Samoylova, C.P. Venner, T. Facon, A. Spencer, S.Z. Usmani, K. Weisel, M. Mateos, K. Kim, S. Grosicki, K. Suzuki, S. Delimpasi, M. Obreja, A. Zahlten-Kumeli

المصدر: Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 253-254 (2020)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2531137920307112; https://doaj.org/toc/2531-1379

URL الوصول: https://doaj.org/article/02f4fe1d85fa459a867fe5ff7a9e871c

المؤلفون: Philippe Moreau, Keith A. Stewart, Meletios Dimopoulos, David Siegel, Thierry Facon, James Berenson, Noopur Raje, Jesus G. Berdeja, Robert Z. Orlowski, Hui Yang, Haijun Ma, Zandra Klippel, Anita Zahlten‐Kumeli, Khalid Mezzi, Karim Iskander, Maria‐Victoria Mateos

المصدر: Cancer Medicine, Vol 9, Iss 9, Pp 2989-2996 (2020)

مصطلحات موضوعية: carfilzomib, dosing schedule, once‐weekly, relapsed and/or refractory multiple myeloma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/228d0e9245d94238b5930f7eee8ce724

المؤلفون: Dimopoulos M. A., Niesvizky R., Weisel K., Siegel D. S., Hajek R., Mateos M. -V., Cavo M., Huang M., Zahlten-Kumeli A., Moreau P.

المساهمون: Dimopoulos M.A., Niesvizky R., Weisel K., Siegel D.S., Hajek R., Mateos M.-V., Cavo M., Huang M., Zahlten-Kumeli A., Moreau P.

مصطلحات موضوعية: A.R.R.O.W. study, carfilzomib, dexamethasone, progression-free survival, relapsed refractory multiple myeloma

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000521002600002; volume:10; issue:3; firstpage:1; lastpage:13; numberofpages:13; journal:BLOOD CANCER JOURNAL; http://hdl.handle.net/11585/804350; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85081600572; https://www.nature.com/articles/s41408-020-0300-y

الاتاحة: http://hdl.handle.net/11585/804350
https://doi.org/10.1038/s41408-020-0300-y
https://www.nature.com/articles/s41408-020-0300-y

المؤلفون: Quach, Hang, Nooka, Ajay, Samoylova, Olga, Venner, Christopher P., Kim, Kihyun, Facon, Thierry, Spencer, Andrew, Usmani, Saad Z., Grosicki, Sebastian, Suzuki, Kenshi, Delimpasi, Sosana, Weisel, Katja, Obreja, Mihaela, Zahlten‐Kumeli, Anita, Mateos, Maria‐Victoria

المساهمون: Amgen

المصدر: British Journal of Haematology ; volume 194, issue 4, page 784-788 ; ISSN 0007-1048 1365-2141

الاتاحة: http://dx.doi.org/10.1111/bjh.17541
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17541
https://onlinelibrary.wiley.com/doi/full-xml/10.1111/bjh.17541

المؤلفون: Siegel, David, Weisel, Katja, Zahlten-Kumeli, Anita, Medhekar, Rohan, Ding, Bifeng, Leleu, Xavier

المساهمون: Error! Hyperlink reference not valid.

المصدر: Leukemia & Lymphoma ; volume 62, issue 12, page 3002-3010 ; ISSN 1042-8194 1029-2403

الاتاحة: https://doi.org/10.1080/10428194.2021.1941927
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1941927

المؤلفون: Moreau, P., Stewart, A.K., Dimopoulos, M.‐A., Siegel, D., Facon, T., Berenson, J., Raje, N., Berdeja, J.G., Orlowski, R.Z., Yang, H., Ma, H., Klippel, Z., Zahlten‐Kumeli, A., Mezzi, K., Iskander, K., Mateos, M.‐V.

المصدر: HemaSphere ; volume 3, issue S1, page 260 ; ISSN 2572-9241 2572-9241

الاتاحة: http://dx.doi.org/10.1097/01.hs9.0000560736.46354.bc
https://onlinelibrary.wiley.com/doi/pdf/10.1097/01.HS9.0000560736.46354.bc

المؤلفون: Moreau, Philippe, Kumar, Shaji, Boccia, Ralph, Iida, Shinsuke, Goldschmidt, Hartmut, Cocks, Kim, Trigg, Andrew, Zahlten-Kumeli, Anita, Yucel, Emre, Panjabi, Sumeet S., Dimopoulos, Meletios

المساهمون: Amgen

المصدر: Leukemia ; volume 33, issue 12, page 2934-2946 ; ISSN 0887-6924 1476-5551

الاتاحة: http://dx.doi.org/10.1038/s41375-019-0480-2
http://www.nature.com/articles/s41375-019-0480-2.pdf
http://www.nature.com/articles/s41375-019-0480-2

المؤلفون: Saad Z Usmani, Hang Quach, Maria-Victoria Mateos, Ola Landgren, Xavier Leleu, David Siegel, Katja Weisel, Maria Gavriatopoulou, Albert Oriol, Neil Rabin, Ajay Nooka, Ming Qi, Meral Beksac, Andrzej Jakubowiak, Bifeng Ding, Anita Zahlten-Kumeli, Akeem Yusuf, Meletios Dimopoulos

المصدر: The Lancet Oncology. 23:65-76

مصطلحات موضوعية: Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::620f82aa5e8321e8509c30d681919497
https://doi.org/10.1016/s1470-2045(21)00579-9

المؤلفون: Xavier Leleu, Zandra Klippel, David S. Siegel, Maria-Victoria Mateos, Meletios A. Dimopoulos, Hang Quach, Ola Landgren, Saad Z. Usmani, Katja Weisel, Anita Zahlten-Kumeli, Hui Yang

المصدر: The Lancet. 396:186-197

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Population, Phases of clinical research, 030204 cardiovascular system & hematology, Dexamethasone, Young Adult, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Infusions, Intravenous, education, Aged, Lenalidomide, Isatuximab, education.field_of_study, Bortezomib, business.industry, Antibodies, Monoclonal, Daratumumab, General Medicine, Middle Aged, Carfilzomib, Treatment Outcome, chemistry, Chronic Disease, Female, Neoplasm Recurrence, Local, Multiple Myeloma, business, Oligopeptides, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c9a716c8aff30ea5d66e9748c624a1a
https://doi.org/10.1016/s0140-6736(20)30734-0

المؤلفون: Usmani, S.Z. Quach, H. Mateos, M.-V. Landgren, O. Leleu, X. Siegel, D. Weisel, K. Gavriatopoulou, M. Oriol, A. Rabin, N. Nooka, A. Qi, M. Beksac, M. Jakubowiak, A. Ding, B. Zahlten-Kumeli, A. Yusuf, A. Dimopoulos, M.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2127::71a1e1f2d4205be5bf34ac51b25563e4
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3118804

المؤلفون: Usmani SZ, Quach H, Mateos MV, Landgren O, Leleu X, Siegel D, Weisel K, Gavriatopoulou M, Oriol A, Rabin N, Nooka A, Qi M, Beksac M, Jakubowiak A, Ding B, Zahlten-Kumeli A, Yusuf A, Dimopoulos M

المصدر: LANCET ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::1fab7df764756a49ab07f459a6476e0a
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5250

المؤلفون: Philippe Moreau, Naoki Takezako, Meletios A. Dimopoulos, Anita Zahlten-Kumeli, Wee Joo Chng, Mei Huang, Martina Sersch, Shang-Yi Huang, Julia Li, Jae Hoon Lee, Shinsuke Iida

المصدر: International Journal of Hematology. 110:466-473

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Subgroup analysis, Risk Assessment, Dexamethasone, Drug Administration Schedule, Bortezomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Asian People, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Adverse effect, Survival rate, Multiple myeloma, business.industry, Hematology, medicine.disease, Carfilzomib, Survival Rate, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Proteasome inhibitor, Multiple Myeloma, business, Oligopeptides, Proteasome Inhibitors, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b2ead2b97f8e37d10ee27056644bb3
https://doi.org/10.1007/s12185-019-02704-z

المؤلفون: Philippe Moreau, Artur Jurczyszyn, Bruno Paiva, Zandra Klippel, Meletios A. Dimopoulos, Ludek Pour, Ruben Niesvizky, Muhtarjan Osman, Roman Hájek, Jesús F. San-Miguel, Anita Zahlten-Kumeli, Lugui Qiu, Jae Hoon Lee, Thierry Facon

المصدر: Blood. 133:1953-1963

مصطلحات موضوعية: Adult, Male, Melphalan, medicine.medical_specialty, Immunology, Population, Biochemistry, Gastroenterology, Bortezomib, chemistry.chemical_compound, Prednisone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, education, Multiple myeloma, Aged, Aged, 80 and over, education.field_of_study, business.industry, Hazard ratio, Cell Biology, Hematology, Middle Aged, medicine.disease, Carfilzomib, Progression-Free Survival, Transplantation, Treatment Outcome, chemistry, Female, Multiple Myeloma, business, Oligopeptides, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3046f502ebac6f95ea6607b78467fef9
https://doi.org/10.1182/blood-2018-09-874396

المؤلفون: Elizabeth Catherine Smyth, Joseph Chao, Kei Muro, Priscilla Yen, Rolando Eduardo Yanes, Anita Zahlten-Kumeli, Sun Young Rha

المصدر: Journal of Clinical Oncology. 40:TPS4164-TPS4164

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c70ff171b2df7eecbf1c7af24878802d
https://doi.org/10.1200/jco.2022.40.16_suppl.tps4164

المؤلفون: Quach, H, Nooka, A, Samoylova, O, Venner, CP, Kim, K, Facon, T, Spencer, A, Usmani, SZ, Grosicki, S, Suzuki, K, Delimpasi, S, Weisel, K, Obreja, M, Zahlten-Kumeli, A, Mateos, M-V

Relation: Quach, H., Nooka, A., Samoylova, O., Venner, C. P., Kim, K., Facon, T., Spencer, A., Usmani, S. Z., Grosicki, S., Suzuki, K., Delimpasi, S., Weisel, K., Obreja, M., Zahlten-Kumeli, A. & Mateos, M. -V. (2021). Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy. BRITISH JOURNAL OF HAEMATOLOGY, 194 (4), pp.784-788. https://doi.org/10.1111/bjh.17541.; http://hdl.handle.net/11343/298604

الاتاحة: http://hdl.handle.net/11343/298604

المؤلفون: Maria-Victoria Mateos, David S. Siegel, Anita Zahlten-Kumeli, Katja Weisel, Ruben Niesvizky, Roman Hájek, Philippe Moreau, Meletios A. Dimopoulos, Michele Cavo, Mei Huang

المساهمون: Dimopoulos M.A., Niesvizky R., Weisel K., Siegel D.S., Hajek R., Mateos M.-V., Cavo M., Huang M., Zahlten-Kumeli A., Moreau P.

المصدر: Blood Cancer Journal
Blood Cancer Journal, Vol 10, Iss 3, Pp 1-13 (2020)

مصطلحات موضوعية: Male, medicine.medical_specialty, Population, Renal function, Subgroup analysis, Gastroenterology, lcsh:RC254-282, Article, chemistry.chemical_compound, Medical research, Internal medicine, Medicine, Humans, Progression-free survival, Dosing, education, Aged, Cancer, Aged, 80 and over, education.field_of_study, business.industry, Hazard ratio, Hematology, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Carfilzomib, Confidence interval, Progression-Free Survival, A.R.R.O.W. study, carfilzomib, dexamethasone, progression-free survival, relapsed refractory multiple myeloma, Oncology, chemistry, Disease Progression, Female, business, Multiple Myeloma, Oligopeptides

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5921ff9d48e1f45f5eb44a49ce54c5f
http://hdl.handle.net/11585/804350

المؤلفون: Philippe Moreau, Kevin W. Song, Anita Zahlten-Kumeli, James R. Berenson, Meletios A. Dimopoulos, A. Keith Stewart, Mei Huang, Antonio Lazzaro, Maria-Victoria Mateos, Katja Weisel

المصدر: The Lancet Oncology. 19:953-964

مصطلحات موضوعية: Male, medicine.medical_specialty, Population, Phases of clinical research, Lung injury, Risk Assessment, Dexamethasone, Disease-Free Survival, Drug Administration Schedule, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, Recurrence, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Neoplasm Invasiveness, Infusions, Intravenous, education, Lenalidomide, Neoplasm Staging, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Bortezomib, Hazard ratio, Prognosis, Interim analysis, Survival Analysis, Carfilzomib, Treatment Outcome, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, business, Oligopeptides, Proteasome Inhibitors, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9af96897fd74b777ca6b00da3ff9a605
https://doi.org/10.1016/s1470-2045(18)30354-1

المؤلفون: Quach, Hang, Nooka, Ajay, Samoylova, Olga, Venner, Christopher, Kim, Kihyun, Facon, Thierry, Spencer, Andrew, Usmani, Saad, Grosicki, Sebastian, Suzuki, Kenshi, Delimpasi, Sosana, Weisel, Katja, Obreja, Mihaela, Zahlten-Kumeli, Anita, Mateos, Maria-Victoria

المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 20, page S294 ; ISSN 2152-2650

الاتاحة: http://dx.doi.org/10.1016/s2152-2650(20)30930-7
https://api.elsevier.com/content/article/PII:S2152265020309307?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2152265020309307?httpAccept=text/plain

المؤلفون: Hartmut Goldschmidt, Amy S. Kimball, Philippe Moreau, Katja Weisel, Ruben Niesvizky, Shibao Feng, Vania Hungria, Robert Z. Orlowski, Douglas E. Joshua, Heinz Ludwig, Meletios A. Dimopoulos, Leonard Minuk, Roman Hájek, Thierry Facon, Anita Zahlten-Kumeli, Wee Joo Chng, Albert Oriol

المصدر: The Lancet Oncology. 18:1327-1337

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Population, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Outpatient clinic, education, Dexamethasone, Multiple myeloma, education.field_of_study, business.industry, Bortezomib, Interim analysis, medicine.disease, Carfilzomib, Surgery, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Proteasome inhibitor, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::80890a22244c610a17658a571006bbcf
https://doi.org/10.1016/s1470-2045(17)30578-8